Zeus has hired Padraic “Paddy” O’Brien as CEO from Becton, Dickinson and Co. effective April 1, the medical tubing supplier said today. O’Brien is worldwide president of BD Peripheral Intervention, where he “developed an extensive and consistent track record of delivering durable, sustainable growth while creating a winning culture,” Zeus said … [Read more...] about Zeus hires new CEO from Becton Dickinson
BD
BD initiates IDE trial of stent for treating peripheral arterial disease
BD (NYSE: BDX) announced today that it enrolled the first patient in a trial of its Vascular Covered Stent for treating peripheral arterial disease (PAD). Franklin Lakes, New Jersey–based BD is evaluating the safety and effectiveness of the stent in its AGILITY FDA investigational device exemption (IDE) trial. The self-expanding, low-profile, … [Read more...] about BD initiates IDE trial of stent for treating peripheral arterial disease
BD launches SiteRite vascular access ultrasound system
BD (NYSE:BD) announced today that it launched its new SiteRite 9 advanced ultrasound system for helping with vascular access device placement. Franklin Lakes, New Jersey-based BD designed the system to help improve clinician efficiency when placing these devices. They include peripherally inserted central catheters (PICCs), central venous … [Read more...] about BD launches SiteRite vascular access ultrasound system
BD enrolls first patient in study of stent graft for treating portal hypertension
BD (NYSE:BDX) announced today that it completed the enrollment of the first patient in a trial of its Liverty TIPS stent graft. Franklin Lakes, New Jersey-based BD's ARCH FDA investigational device exemption (IDE) study evaluates the safety and effectiveness of Liverty. The global, prospective, multi-center, single-arm clinical study looks at … [Read more...] about BD enrolls first patient in study of stent graft for treating portal hypertension
BD expands availability of all-in-one flush pre-filled syringe
BD (NYSE:BDX) announced today that it expanded customer availability for its all-in-one pre-filled flush syringe. Franklin Lakes, New Jersey-based BD designed its PosiFlush SafeScrub syringe with an integrated disinfection unit. It reinforces compliance to infection prevention guidelines, simplifying nursing workflow. BD built the active … [Read more...] about BD expands availability of all-in-one flush pre-filled syringe
BD issues urgent field safety notice for Venovo venous stent system
BD has issued an urgent field safety notice for its Venovo venous stent system. The notice out of Germany warns of potential delayed deployment and silicone embolization if the proximal end of the Venovo venous stent system does not immediately expand upon deployment and remains connected to the stent cushion on the delivery system. According … [Read more...] about BD issues urgent field safety notice for Venovo venous stent system
BD initiates first-in-human trial of sirolimus drug-coated balloon
BD today announced it started enrollment in the first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB). The Prevision trial is a prospective, multi-center, single-arm, non-randomized study that will evaluate the safety of BD's DCB in the treatment of peripheral arterial disease (PAD) in the femoropopliteal arteries. The company … [Read more...] about BD initiates first-in-human trial of sirolimus drug-coated balloon
The 24 best medical device innovations of 2022
The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products … [Read more...] about The 24 best medical device innovations of 2022
BD issues Class I recall of some intraosseous needle set kits and drivers
BD (NYSE:BDX) has issued a class I recall of its intraosseous needle set kits for its intraosseous infusion system. BD issued the recall of its intraosseous needle set kits, manual driver kits and powered drivers due to three separate issues. The needle set kits stylets could be difficult to separate from the needle or not separate at all. The … [Read more...] about BD issues Class I recall of some intraosseous needle set kits and drivers
BD acquires Venclose and its RF ablation technology
BD (NYSE:BDX) announced today that it acquired Venclose and its solutions for treating chronic venous insufficiency (CVI). CVI occurs as the result of malfunctioning valves and can lead to varicose veins. Venclose’s CVI treatment uses radio frequency (RF) ablation technology, with its catheters potentially reducing post-operative pain and … [Read more...] about BD acquires Venclose and its RF ablation technology
